🇺🇸 FDA
Patent

US 10822299

Compounds and methods for hematopoietic regeneration

granted A61PA61P43/00A61P7/00

Quick answer

US patent 10822299 (Compounds and methods for hematopoietic regeneration) held by The Regents of the University of California expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P43/00, A61P7/00, A61P7/06